| Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment M Daskalakis, TT Nguyen, C Nguyen, P Guldberg, G Köhler, ... Blood, The Journal of the American Society of Hematology 100 (8), 2957-2964, 2002 | 686 | 2002 |
| DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats D Brocks, CR Schmidt, M Daskalakis, HS Jang, NM Shah, D Li, J Li, ... Nature genetics 49 (7), 1052-1060, 2017 | 275 | 2017 |
| Telomerase inhibitor imetelstat in patients with essential thrombocythemia GM Baerlocher, E Oppliger Leibundgut, OG Ottmann, G Spitzer, ... New England Journal of Medicine 373 (10), 920-928, 2015 | 208 | 2015 |
| Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis J Wilpert, KG Fischer, P Pisarski, T Wiech, M Daskalakis, A Ziegler, ... Nephrology Dialysis Transplantation 25 (11), 3778-3786, 2010 | 140 | 2010 |
| Decitabine M Daskalakis, N Blagitko-Dorfs, B Hackanson Small Molecules in Oncology, 131-157, 2009 | 70 | 2009 |
| Reactivation of endogenous retroviral elements via treatment with DNMT-and HDAC-inhibitors M Daskalakis, D Brocks, YH Sheng, MS Islam, A Ressnerova, Y Assenov, ... Cell Cycle 17 (7), 811-822, 2018 | 66 | 2018 |
| Decitabine B Hackanson, M Daskalakis Small Molecules in Oncology, 269-297, 2014 | 56 | 2014 |
| Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis M Daskalakis, G Colucci, P Keller, S Rochat, T Silzle, FD Biasiutti, ... Cytometry Part B: Clinical Cytometry 86 (6), 397-409, 2014 | 55 | 2014 |
| Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2’-deoxycytidine (decitabine) M Lübbert, M Daskalakis, R Kunzmann, M Engelhardt, Y Guo, ... Leukemia research 28 (12), 1267-1271, 2004 | 43 | 2004 |
| Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs W Lange, M Daskalakis, J Finke, G Dölken FEBS letters 338 (2), 175-178, 1994 | 39 | 1994 |
| Platelet transfusion induces alloimmunization to D and non-D Rhesus antigens J Reckhaus, M Jutzi, S Fontana, VU Bacher, M Vogt, M Daskalakis, ... Transfusion medicine and hemotherapy 45 (3), 167-172, 2018 | 29 | 2018 |
| Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients DA Sanoyan, K Seipel, U Bacher, MN Kronig, N Porret, G Wiedemann, ... BMC cancer 23 (1), 345, 2023 | 19 | 2023 |
| Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: a comparison between Swiss and American population-based cancer registries S Benzarti, M Daskalakis, A Feller, VU Bacher, A Schnegg-Kaufmann, ... Cancer epidemiology 59, 51-57, 2019 | 18 | 2019 |
| Cytosine demethylation of the proteinase-3/myeloblastin primary granule protease gene during phagocyte development M Lübbert, A Tobler, M Daskalakis Leukemia 13 (9), 1420-1427, 1999 | 18 | 1999 |
| CAR T-cell persistence correlates with improved outcome in patients with B-cell lymphoma V Wittibschlager, U Bacher, K Seipel, N Porret, G Wiedemann, ... International journal of molecular sciences 24 (6), 5688, 2023 | 13 | 2023 |
| Azacitidine is effective for targeting leukemia-initiating cells in juvenile myelomonocytic leukemia CF Krombholz, L Gallego-Villar, SS Sahoo, PK Panda, MW Wlodarski, ... Leukemia 33 (7), 1805-1810, 2019 | 13 | 2019 |
| Early use of corticosteroids following CAR T-cell therapy correlates with reduced risk of high-grade CRS without negative impact on neurotoxicity or treatment outcome T Lakomy, D Akhoundova, H Nilius, MN Kronig, U Novak, M Daskalakis, ... Biomolecules 13 (2), 382, 2023 | 12 | 2023 |
| Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party O Penack, C Peczynski, C Koenecke, E Polge, A Kuhnl, N Fegueux, ... Journal for immunotherapy of cancer 11 (4), 2023 | 12 | 2023 |
| Platelet transfusion—insights from current practice to future development A Capraru, KA Jalowiec, C Medri, M Daskalakis, SS Zeerleder, ... Journal of clinical medicine 10 (9), 1990, 2021 | 12 | 2021 |
| Thromboembolic complications in autoimmune hemolytic anemia: Retrospective study DT Schär, M Daskalakis, B Mansouri, A Rovo, S Zeerleder European Journal of Haematology 108 (1), 45-51, 2022 | 10 | 2022 |
